SIRT1 and fatty liver disease: Moreover, SIRT1 activates AMPK, which leads to lipid-lowering effects in vitro and in vivo.132 SIRT2 prevents liver steatosis and lipid metabolic disorders by deacetylation of hepatocyte nuclear factor 4α.133 Additionally, SIRT3 acts as a bridge in the lipid metabolism pathway.